BioRegenx, Inc.
Get $10 bonus on your first $100 deposit for BRGX
Get $10 bonus on your first $100 deposit for BRGX
BioRegenx, Inc. (BRGX) Stock Competitors & Peer Comparison
See (BRGX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BRGX | $0.01 | -1.90% | 10.9M | -1.14 | -$0.01 | N/A |
| PMCUF | $92.84 | +11.86% | 9.7B | 59.90 | $1.55 | +0.46% |
| MTHRF | $11.00 | +0.00% | 7.5B | 26.19 | $0.42 | +1.19% |
| MTHRY | $5.28 | +2.52% | 7.1B | 25.00 | $0.21 | N/A |
| PANHF | $1.55 | -12.22% | 3.3B | 51.50 | $0.03 | N/A |
| PIAHY | $4.40 | +0.00% | 2.3B | 88.00 | $0.05 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +0.17% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| CRWRF | $24.20 | +0.00% | 850.7M | 44.00 | $0.55 | +1.84% |
| SMSZF | $8.56 | +0.00% | 702.6M | 17.83 | $0.48 | +2.41% |
Stock Comparison
BRGX vs PMCUF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PMCUF has a market cap of 9.7B. Regarding current trading prices, BRGX is priced at $0.01, while PMCUF trades at $92.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PMCUF's P/E ratio is 59.90. In terms of profitability, BRGX's ROE is +5.32%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, BRGX is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check PMCUF's competition here
BRGX vs MTHRF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MTHRF has a market cap of 7.5B. Regarding current trading prices, BRGX is priced at $0.01, while MTHRF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MTHRF's P/E ratio is 26.19. In terms of profitability, BRGX's ROE is +5.32%, compared to MTHRF's ROE of +0.18%. Regarding short-term risk, BRGX and MTHRF have similar daily volatility (0.00).Check MTHRF's competition here
BRGX vs MTHRY Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MTHRY has a market cap of 7.1B. Regarding current trading prices, BRGX is priced at $0.01, while MTHRY trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MTHRY's P/E ratio is 25.00. In terms of profitability, BRGX's ROE is +5.32%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, BRGX is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check MTHRY's competition here
BRGX vs PANHF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PANHF has a market cap of 3.3B. Regarding current trading prices, BRGX is priced at $0.01, while PANHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PANHF's P/E ratio is 51.50. In terms of profitability, BRGX's ROE is +5.32%, compared to PANHF's ROE of +0.04%. Regarding short-term risk, BRGX and PANHF have similar daily volatility (0.00).Check PANHF's competition here
BRGX vs PIAHY Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PIAHY has a market cap of 2.3B. Regarding current trading prices, BRGX is priced at $0.01, while PIAHY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PIAHY's P/E ratio is 88.00. In terms of profitability, BRGX's ROE is +5.32%, compared to PIAHY's ROE of +0.04%. Regarding short-term risk, BRGX and PIAHY have similar daily volatility (0.00).Check PIAHY's competition here
BRGX vs CMPVF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, BRGX is priced at $0.01, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, BRGX's ROE is +5.32%, compared to CMPVF's ROE of +0.01%. Regarding short-term risk, BRGX is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check CMPVF's competition here
BRGX vs CMPUY Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, BRGX is priced at $0.01, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, BRGX's ROE is +5.32%, compared to CMPUY's ROE of +0.01%. Regarding short-term risk, BRGX and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
BRGX vs CRWRF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CRWRF has a market cap of 850.7M. Regarding current trading prices, BRGX is priced at $0.01, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, BRGX's ROE is +5.32%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, BRGX is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check CRWRF's competition here
BRGX vs SMSZF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, BRGX is priced at $0.01, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, BRGX's ROE is +5.32%, compared to SMSZF's ROE of +0.15%. Regarding short-term risk, BRGX and SMSZF have similar daily volatility (0.00).Check SMSZF's competition here
BRGX vs RSLBF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, RSLBF has a market cap of 699.6M. Regarding current trading prices, BRGX is priced at $0.01, while RSLBF trades at $19.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas RSLBF's P/E ratio is 27.56. In terms of profitability, BRGX's ROE is +5.32%, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, BRGX and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
BRGX vs VHIBF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, VHIBF has a market cap of 319.3M. Regarding current trading prices, BRGX is priced at $0.01, while VHIBF trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas VHIBF's P/E ratio is 72.14. In terms of profitability, BRGX's ROE is +5.32%, compared to VHIBF's ROE of +0.03%. Regarding short-term risk, BRGX and VHIBF have similar daily volatility (0.00).Check VHIBF's competition here
BRGX vs SMDCF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, BRGX is priced at $0.01, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, BRGX's ROE is +5.32%, compared to SMDCF's ROE of N/A. Regarding short-term risk, BRGX and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
BRGX vs COGZF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, COGZF has a market cap of 265M. Regarding current trading prices, BRGX is priced at $0.01, while COGZF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas COGZF's P/E ratio is 25.83. In terms of profitability, BRGX's ROE is +5.32%, compared to COGZF's ROE of +0.29%. Regarding short-term risk, BRGX and COGZF have similar daily volatility (0.00).Check COGZF's competition here
BRGX vs KSIOF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, KSIOF has a market cap of 259.6M. Regarding current trading prices, BRGX is priced at $0.01, while KSIOF trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas KSIOF's P/E ratio is -271.00. In terms of profitability, BRGX's ROE is +5.32%, compared to KSIOF's ROE of -0.04%. Regarding short-term risk, BRGX is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check KSIOF's competition here
BRGX vs DLHTF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, BRGX is priced at $0.01, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, BRGX's ROE is +5.32%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, BRGX and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
BRGX vs VPAHF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, BRGX is priced at $0.01, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, BRGX's ROE is +5.32%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, BRGX and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
BRGX vs ACMLF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ACMLF has a market cap of 149.3M. Regarding current trading prices, BRGX is priced at $0.01, while ACMLF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ACMLF's P/E ratio is 43.70. In terms of profitability, BRGX's ROE is +5.32%, compared to ACMLF's ROE of +0.20%. Regarding short-term risk, BRGX and ACMLF have similar daily volatility (0.00).Check ACMLF's competition here
BRGX vs SUSRF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, BRGX is priced at $0.01, while SUSRF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, BRGX's ROE is +5.32%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, BRGX and SUSRF have similar daily volatility (0.00).Check SUSRF's competition here
BRGX vs ONVVF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, BRGX is priced at $0.01, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, BRGX's ROE is +5.32%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, BRGX and ONVVF have similar daily volatility (0.00).Check ONVVF's competition here
BRGX vs CSAMF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, BRGX is priced at $0.01, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, BRGX's ROE is +5.32%, compared to CSAMF's ROE of -0.85%. Regarding short-term risk, BRGX and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
BRGX vs HITC Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, BRGX is priced at $0.01, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas HITC's P/E ratio is -14.75. In terms of profitability, BRGX's ROE is +5.32%, compared to HITC's ROE of -0.79%. Regarding short-term risk, BRGX is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check HITC's competition here
BRGX vs MDPEF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, BRGX is priced at $0.01, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, BRGX's ROE is +5.32%, compared to MDPEF's ROE of N/A. Regarding short-term risk, BRGX and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here
BRGX vs TREIF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, BRGX is priced at $0.01, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas TREIF's P/E ratio is -3.46. In terms of profitability, BRGX's ROE is +5.32%, compared to TREIF's ROE of -1.90%. Regarding short-term risk, BRGX is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check TREIF's competition here
BRGX vs EMOR Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, EMOR has a market cap of 30.6M. Regarding current trading prices, BRGX is priced at $0.01, while EMOR trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas EMOR's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to EMOR's ROE of +0.06%. Regarding short-term risk, BRGX is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check EMOR's competition here
BRGX vs VASO Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, VASO has a market cap of 28.8M. Regarding current trading prices, BRGX is priced at $0.01, while VASO trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas VASO's P/E ratio is 16.37. In terms of profitability, BRGX's ROE is +5.32%, compared to VASO's ROE of -0.15%. Regarding short-term risk, BRGX is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check VASO's competition here
BRGX vs RTNXF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, BRGX is priced at $0.01, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, BRGX's ROE is +5.32%, compared to RTNXF's ROE of -6.31%. Regarding short-term risk, BRGX is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check RTNXF's competition here
BRGX vs HDSLF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, BRGX is priced at $0.01, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, BRGX's ROE is +5.32%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, BRGX is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check HDSLF's competition here
BRGX vs DGNOF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, DGNOF has a market cap of 18.4M. Regarding current trading prices, BRGX is priced at $0.01, while DGNOF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas DGNOF's P/E ratio is -4.52. In terms of profitability, BRGX's ROE is +5.32%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, BRGX is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check DGNOF's competition here
BRGX vs THKKF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, BRGX is priced at $0.01, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas THKKF's P/E ratio is -1.51. In terms of profitability, BRGX's ROE is +5.32%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, BRGX and THKKF have similar daily volatility (0.00).Check THKKF's competition here
BRGX vs CRVW Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CRVW has a market cap of 17.5M. Regarding current trading prices, BRGX is priced at $0.01, while CRVW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CRVW's P/E ratio is -3.00. In terms of profitability, BRGX's ROE is +5.32%, compared to CRVW's ROE of +0.17%. Regarding short-term risk, BRGX and CRVW have similar daily volatility (0.00).Check CRVW's competition here
BRGX vs MNNDF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, BRGX is priced at $0.01, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, BRGX's ROE is +5.32%, compared to MNNDF's ROE of N/A. Regarding short-term risk, BRGX is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check MNNDF's competition here
BRGX vs WLSS Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, WLSS has a market cap of 12.7M. Regarding current trading prices, BRGX is priced at $0.01, while WLSS trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas WLSS's P/E ratio is -460.00. In terms of profitability, BRGX's ROE is +5.32%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, BRGX is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check WLSS's competition here
BRGX vs PBSV Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PBSV has a market cap of 11.5M. Regarding current trading prices, BRGX is priced at $0.01, while PBSV trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PBSV's P/E ratio is -50.00. In terms of profitability, BRGX's ROE is +5.32%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, BRGX is less volatile compared to PBSV. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check PBSV's competition here
BRGX vs CDXFF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, BRGX is priced at $0.01, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, BRGX's ROE is +5.32%, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, BRGX and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here
BRGX vs CMHSF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CMHSF has a market cap of 9.5M. Regarding current trading prices, BRGX is priced at $0.01, while CMHSF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CMHSF's P/E ratio is -3.53. In terms of profitability, BRGX's ROE is +5.32%, compared to CMHSF's ROE of +0.28%. Regarding short-term risk, BRGX and CMHSF have similar daily volatility (0.00).Check CMHSF's competition here
BRGX vs HBCNF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, BRGX is priced at $0.01, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, BRGX's ROE is +5.32%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, BRGX is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check HBCNF's competition here
BRGX vs CMPD Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CMPD has a market cap of 8.3M. Regarding current trading prices, BRGX is priced at $0.01, while CMPD trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CMPD's P/E ratio is -14.22. In terms of profitability, BRGX's ROE is +5.32%, compared to CMPD's ROE of -0.04%. Regarding short-term risk, BRGX and CMPD have similar daily volatility (0.00).Check CMPD's competition here
BRGX vs SPLTF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, BRGX is priced at $0.01, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, BRGX's ROE is +5.32%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, BRGX and SPLTF have similar daily volatility (0.00).Check SPLTF's competition here
BRGX vs VYND Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, BRGX is priced at $0.01, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas VYND's P/E ratio is -43.00. In terms of profitability, BRGX's ROE is +5.32%, compared to VYND's ROE of +0.81%. Regarding short-term risk, BRGX and VYND have similar daily volatility (0.00).Check VYND's competition here
BRGX vs CRBKF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, BRGX is priced at $0.01, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, BRGX's ROE is +5.32%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, BRGX and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
BRGX vs DOCRF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, BRGX is priced at $0.01, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, BRGX's ROE is +5.32%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, BRGX and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
BRGX vs UDOCF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, UDOCF has a market cap of 6.1M. Regarding current trading prices, BRGX is priced at $0.01, while UDOCF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas UDOCF's P/E ratio is -2.37. In terms of profitability, BRGX's ROE is +5.32%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, BRGX is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check UDOCF's competition here
BRGX vs IQAIF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, BRGX is priced at $0.01, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas IQAIF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, BRGX is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check IQAIF's competition here
BRGX vs AIMLF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, AIMLF has a market cap of 4.4M. Regarding current trading prices, BRGX is priced at $0.01, while AIMLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas AIMLF's P/E ratio is -1.32. In terms of profitability, BRGX's ROE is +5.32%, compared to AIMLF's ROE of -5.05%. Regarding short-term risk, BRGX is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check AIMLF's competition here
BRGX vs CBDS Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, BRGX is priced at $0.01, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CBDS's P/E ratio is -1.49. In terms of profitability, BRGX's ROE is +5.32%, compared to CBDS's ROE of +0.68%. Regarding short-term risk, BRGX is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check CBDS's competition here
BRGX vs RQHTF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, BRGX is priced at $0.01, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, BRGX's ROE is +5.32%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, BRGX and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
BRGX vs NDATF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, NDATF has a market cap of 2.5M. Regarding current trading prices, BRGX is priced at $0.01, while NDATF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas NDATF's P/E ratio is -6.00. In terms of profitability, BRGX's ROE is +5.32%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, BRGX and NDATF have similar daily volatility (0.00).Check NDATF's competition here
BRGX vs RYAHF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, BRGX is priced at $0.01, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, BRGX's ROE is +5.32%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, BRGX and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here
BRGX vs RSLT Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, RSLT has a market cap of 2.2M. Regarding current trading prices, BRGX is priced at $0.01, while RSLT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas RSLT's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to RSLT's ROE of N/A. Regarding short-term risk, BRGX and RSLT have similar daily volatility (0.00).Check RSLT's competition here
BRGX vs EBYH Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, EBYH has a market cap of 1.9M. Regarding current trading prices, BRGX is priced at $0.01, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas EBYH's P/E ratio is -5.42. In terms of profitability, BRGX's ROE is +5.32%, compared to EBYH's ROE of +0.09%. Regarding short-term risk, BRGX is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check EBYH's competition here
BRGX vs MDBIF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, BRGX is priced at $0.01, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MDBIF's P/E ratio is -0.25. In terms of profitability, BRGX's ROE is +5.32%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, BRGX and MDBIF have similar daily volatility (0.00).Check MDBIF's competition here
BRGX vs CSOC Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CSOC has a market cap of 1.4M. Regarding current trading prices, BRGX is priced at $0.01, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CSOC's P/E ratio is 0.17. In terms of profitability, BRGX's ROE is +5.32%, compared to CSOC's ROE of -3.87%. Regarding short-term risk, BRGX is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check CSOC's competition here
BRGX vs DSOL Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, DSOL has a market cap of 1.2M. Regarding current trading prices, BRGX is priced at $0.01, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas DSOL's P/E ratio is -0.04. In terms of profitability, BRGX's ROE is +5.32%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, BRGX and DSOL have similar daily volatility (0.00).Check DSOL's competition here
BRGX vs MDXL Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MDXL has a market cap of 1.2M. Regarding current trading prices, BRGX is priced at $0.01, while MDXL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MDXL's P/E ratio is -0.28. In terms of profitability, BRGX's ROE is +5.32%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, BRGX and MDXL have similar daily volatility (0.00).Check MDXL's competition here
BRGX vs MITI Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MITI has a market cap of 1M. Regarding current trading prices, BRGX is priced at $0.01, while MITI trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MITI's P/E ratio is -0.13. In terms of profitability, BRGX's ROE is +5.32%, compared to MITI's ROE of +0.17%. Regarding short-term risk, BRGX is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check MITI's competition here
BRGX vs EKGGF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, BRGX is priced at $0.01, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas EKGGF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to EKGGF's ROE of +1.04%. Regarding short-term risk, BRGX and EKGGF have similar daily volatility (0.00).Check EKGGF's competition here
BRGX vs EVAHF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, EVAHF has a market cap of 662.2K. Regarding current trading prices, BRGX is priced at $0.01, while EVAHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas EVAHF's P/E ratio is -0.27. In terms of profitability, BRGX's ROE is +5.32%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, BRGX and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here
BRGX vs DTRK Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, DTRK has a market cap of 549.5K. Regarding current trading prices, BRGX is priced at $0.01, while DTRK trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas DTRK's P/E ratio is -4.78. In terms of profitability, BRGX's ROE is +5.32%, compared to DTRK's ROE of +3.54%. Regarding short-term risk, BRGX is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check DTRK's competition here
BRGX vs MDNWF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, BRGX is priced at $0.01, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, BRGX's ROE is +5.32%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, BRGX and MDNWF have similar daily volatility (0.00).Check MDNWF's competition here
BRGX vs USPS Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, USPS has a market cap of 455.1K. Regarding current trading prices, BRGX is priced at $0.01, while USPS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas USPS's P/E ratio is -2.87. In terms of profitability, BRGX's ROE is +5.32%, compared to USPS's ROE of +0.62%. Regarding short-term risk, BRGX and USPS have similar daily volatility (0.00).Check USPS's competition here
BRGX vs PPJE Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PPJE has a market cap of 445.2K. Regarding current trading prices, BRGX is priced at $0.01, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PPJE's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, BRGX and PPJE have similar daily volatility (0.00).Check PPJE's competition here
BRGX vs CTVEF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, BRGX is priced at $0.01, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, BRGX's ROE is +5.32%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, BRGX and CTVEF have similar daily volatility (0.00).Check CTVEF's competition here
BRGX vs LVCE Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, LVCE has a market cap of 381.9K. Regarding current trading prices, BRGX is priced at $0.01, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas LVCE's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to LVCE's ROE of N/A. Regarding short-term risk, BRGX and LVCE have similar daily volatility (0.00).Check LVCE's competition here
BRGX vs ACHKF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, BRGX is priced at $0.01, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, BRGX's ROE is +5.32%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, BRGX and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
BRGX vs NHIQ Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, BRGX is priced at $0.01, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, BRGX's ROE is +5.32%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, BRGX is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check NHIQ's competition here
BRGX vs MDRM Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MDRM has a market cap of 255.1K. Regarding current trading prices, BRGX is priced at $0.01, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MDRM's P/E ratio is -0.20. In terms of profitability, BRGX's ROE is +5.32%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, BRGX and MDRM have similar daily volatility (0.00).Check MDRM's competition here
BRGX vs ALDNF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, BRGX is priced at $0.01, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ALDNF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, BRGX and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
BRGX vs TSTTF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, BRGX is priced at $0.01, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, BRGX's ROE is +5.32%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, BRGX and TSTTF have similar daily volatility (0.00).Check TSTTF's competition here
BRGX vs EMYSF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, BRGX is priced at $0.01, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas EMYSF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, BRGX and EMYSF have similar daily volatility (0.00).Check EMYSF's competition here
BRGX vs RVRC Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, RVRC has a market cap of 130.8K. Regarding current trading prices, BRGX is priced at $0.01, while RVRC trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas RVRC's P/E ratio is -0.35. In terms of profitability, BRGX's ROE is +5.32%, compared to RVRC's ROE of +0.07%. Regarding short-term risk, BRGX and RVRC have similar daily volatility (0.00).Check RVRC's competition here
BRGX vs NEWUF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, BRGX is priced at $0.01, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, BRGX's ROE is +5.32%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, BRGX and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
BRGX vs PASO Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, BRGX is priced at $0.01, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PASO's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to PASO's ROE of +6.20%. Regarding short-term risk, BRGX and PASO have similar daily volatility (0.00).Check PASO's competition here
BRGX vs LFCOF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, LFCOF has a market cap of 71.6K. Regarding current trading prices, BRGX is priced at $0.01, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, BRGX's ROE is +5.32%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, BRGX and LFCOF have similar daily volatility (0.00).Check LFCOF's competition here
BRGX vs REFG Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, BRGX is priced at $0.01, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas REFG's P/E ratio is -0.01. In terms of profitability, BRGX's ROE is +5.32%, compared to REFG's ROE of +0.01%. Regarding short-term risk, BRGX and REFG have similar daily volatility (0.00).Check REFG's competition here
BRGX vs SOFE Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, BRGX is priced at $0.01, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas SOFE's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, BRGX and SOFE have similar daily volatility (0.00).Check SOFE's competition here
BRGX vs HDVY Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, BRGX is priced at $0.01, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas HDVY's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, BRGX and HDVY have similar daily volatility (0.00).Check HDVY's competition here
BRGX vs IGRW Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, BRGX is priced at $0.01, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas IGRW's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, BRGX and IGRW have similar daily volatility (0.00).Check IGRW's competition here
BRGX vs WMGR Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, BRGX is priced at $0.01, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas WMGR's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, BRGX and WMGR have similar daily volatility (0.00).Check WMGR's competition here
BRGX vs SSYNF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, BRGX is priced at $0.01, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, BRGX's ROE is +5.32%, compared to SSYNF's ROE of N/A. Regarding short-term risk, BRGX and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here
BRGX vs TTBLF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, BRGX is priced at $0.01, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, BRGX's ROE is +5.32%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, BRGX is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check TTBLF's competition here
BRGX vs FDBH Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, FDBH has a market cap of 25K. Regarding current trading prices, BRGX is priced at $0.01, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas FDBH's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, BRGX and FDBH have similar daily volatility (0.00).Check FDBH's competition here
BRGX vs NMXS Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, NMXS has a market cap of 18.8K. Regarding current trading prices, BRGX is priced at $0.01, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas NMXS's P/E ratio is -0.05. In terms of profitability, BRGX's ROE is +5.32%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, BRGX and NMXS have similar daily volatility (0.00).Check NMXS's competition here
BRGX vs EWLL Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, EWLL has a market cap of 18.5K. Regarding current trading prices, BRGX is priced at $0.01, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas EWLL's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, BRGX and EWLL have similar daily volatility (0.00).Check EWLL's competition here
BRGX vs NHEL Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, BRGX is priced at $0.01, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas NHEL's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, BRGX and NHEL have similar daily volatility (0.00).Check NHEL's competition here
BRGX vs ORHB Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ORHB has a market cap of 13.8K. Regarding current trading prices, BRGX is priced at $0.01, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ORHB's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, BRGX and ORHB have similar daily volatility (0.00).Check ORHB's competition here
BRGX vs BNVIF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, BRGX is priced at $0.01, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas BNVIF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, BRGX and BNVIF have similar daily volatility (0.00).Check BNVIF's competition here
BRGX vs HLTT Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, BRGX is priced at $0.01, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas HLTT's P/E ratio is -0.00. In terms of profitability, BRGX's ROE is +5.32%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, BRGX and HLTT have similar daily volatility (0.00).Check HLTT's competition here
BRGX vs CGNSF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, BRGX is priced at $0.01, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CGNSF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, BRGX and CGNSF have similar daily volatility (0.00).Check CGNSF's competition here
BRGX vs MOSTQ Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, BRGX is priced at $0.01, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, BRGX's ROE is +5.32%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, BRGX and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
BRGX vs ACNV Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, BRGX is priced at $0.01, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ACNV's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, BRGX and ACNV have similar daily volatility (0.00).Check ACNV's competition here
BRGX vs AHGIF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, BRGX is priced at $0.01, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas AHGIF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, BRGX and AHGIF have similar daily volatility (0.00).Check AHGIF's competition here
BRGX vs BBLNF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, BRGX is priced at $0.01, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas BBLNF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, BRGX and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
BRGX vs ICCO Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, BRGX is priced at $0.01, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ICCO's P/E ratio is -0.01. In terms of profitability, BRGX's ROE is +5.32%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, BRGX and ICCO have similar daily volatility (0.00).Check ICCO's competition here
BRGX vs HSCHF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, HSCHF has a market cap of 1.3K. Regarding current trading prices, BRGX is priced at $0.01, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas HSCHF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, BRGX and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here
BRGX vs PCYS Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, BRGX is priced at $0.01, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas PCYS's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, BRGX is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for BRGX.Check PCYS's competition here
BRGX vs CNONF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, BRGX is priced at $0.01, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas CNONF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, BRGX and CNONF have similar daily volatility (0.00).Check CNONF's competition here
BRGX vs OLMM Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, BRGX is priced at $0.01, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas OLMM's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, BRGX and OLMM have similar daily volatility (0.00).Check OLMM's competition here
BRGX vs ETAOF Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, BRGX is priced at $0.01, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas ETAOF's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, BRGX and ETAOF have similar daily volatility (0.00).Check ETAOF's competition here
BRGX vs LGBI Comparison April 2026
BRGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRGX stands at 10.9M. In comparison, LGBI has a market cap of 50. Regarding current trading prices, BRGX is priced at $0.01, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRGX currently has a P/E ratio of -1.14, whereas LGBI's P/E ratio is N/A. In terms of profitability, BRGX's ROE is +5.32%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, BRGX and LGBI have similar daily volatility (0.00).Check LGBI's competition here